Cipla
Sustainability Report and Carbon Intensity Rankings
Is Cipla doing their part?
Their DitchCarbon score is 59
Cipla has a DitchCarbon Score of 59 out of 100, indicating a moderate level of sustainability in their operations. This score reflects the company’s current carbon intensity, which suggests there is room for improvement in reducing emissions. A higher score would demonstrate a greater commitment to lowering carbon intensity and enhancing environmental sustainability.
This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.
Industry emissions intensity
Very low
Low
Medium
High
Very high
Cipla is a company in the industrial manufacturing sector, which has a carbon intensity ranking of very low. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.
Location emissions intensity
Very low
Low
Medium
High
Very high
Cipla, located in India, operates in a region with a very high carbon intensity rating, indicating significant greenhouse gas emissions per unit of energy produced. This suggests that the company’s sustainability efforts may face challenges due to the high carbon footprint associated with its location’s energy supply.
Unlock 30+ emissions data points on Cipla
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
Unlock 30+ emissions data points on Cipla
Get the emissions intelligence you need, no surveys required.
– Historical Scope 1, 2 and 3 emissions
– Coverage of all industries, product level data
– Emissions forecasting, assurances
17.71%
...this company is doing 17.71% better in emissions than the industry average.
Founded in 1935, Cipla is a leading global pharmaceutical company headquartered in Mumbai, India. Operating in the industrial manufacturing sector, Cipla specializes in the production of over 1000 pharmaceutical products across various therapeutic categories. The company is renowned for its commitment to affordable healthcare and its significant contributions to HIV/AIDS treatment, particularly in Africa.
emission intelligence's platform recommendations for Cipla
Cipla should enhance its environmental performance by investing in cleaner and more efficient machinery and equipment, which could potentially reduce its emissions by 15%.
Bad news, Cipla has yet to commit to SBTi targets
Cipla has not yet established specific commitments with the Science Based Targets initiative (SBTi). This means the company is still in the process of defining its goals for reducing greenhouse gas emissions in line with climate science.
Not participating
Claim this profile
Are you associate with this company?
Help us improve our data and claim this profile.
Our methodology
Read about our emission calculation methodologies, and what the DitchCarbon Score means.
Looking for a specific company?
Search our company directory or contact us for custom data requests.